These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31004607)

  • 41. Extended bipolar left ventricular pacing as a possible therapy for late electrical storm induced by cardiac resynchronization therapy.
    Asvestas D; Balasubramaniam R; Sopher M; Paisey J; Babu GG
    J Electrocardiol; 2017; 50(3):349-352. PubMed ID: 28069274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
    Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy.
    Levine YC; Matos J; Rosenberg MA; Manning WJ; Josephson ME; Buxton AE
    Heart Rhythm; 2016 Feb; 13(2):490-7. PubMed ID: 26409099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure.
    Choi AJ; Thomas SS; Singh JP
    Heart Fail Clin; 2016 Jul; 12(3):423-36. PubMed ID: 27371518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
    Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of implantable cardioverter defibrillator and cardiac resynchronization therapy: an Italian survey study on 220 cardiology departments.
    Inama G; Pedrinazzi C; Landolina M; Oliva F; Senni M; Proclemer A; Berisso MZ; Pirelli S;
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):675-83. PubMed ID: 22002257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance of Implantable Cardioverter-Defibrillator Back-Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta-Analysis.
    Barra S; Providência R; Tang A; Heck P; Virdee M; Agarwal S
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26546574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Right Ventricular Ejection Fraction Is Incremental to Left Ventricular Ejection Fraction for the Prediction of Future Arrhythmic Events in Patients With Systolic Dysfunction.
    Mikami Y; Jolly U; Heydari B; Peng M; Almehmadi F; Zahrani M; Bokhari M; Stirrat J; Lydell CP; Howarth AG; Yee R; White JA
    Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28087564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sudden cardiac death in heart failure.
    Klein L; Hsia H
    Cardiol Clin; 2014 Feb; 32(1):135-44, ix. PubMed ID: 24286584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA; Turner JW; Dec GW
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implantable defibrillators with and without resynchronization for patients with left ventricular dysfunction.
    Narayan SM
    Tex Heart Inst J; 2005; 32(3):358-61. PubMed ID: 16392218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.
    Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I
    Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac resynchronization therapy for patients with cardiac sarcoidosis.
    Sairaku A; Yoshida Y; Nakano Y; Hirayama H; Maeda M; Hashimoto H; Kihara Y
    Europace; 2017 May; 19(5):824-830. PubMed ID: 28339577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
    Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
    Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
    Narducci ML; Biffi M; Ammendola E; Vado A; Campana A; Potenza DR; Iori M; Zanon F; Zacà V; Zoni Berisso M; Bertini M; Lissoni F; Bandini A; Malacrida M; Crea F
    Europace; 2018 Sep; 20(9):1475-1483. PubMed ID: 29186401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
    Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Utility of Frailty Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy.
    Kubala M; Guédon-Moreau L; Anselme F; Klug D; Bertaina G; Traullé S; Buiciuc O; Savouré A; Diouf M; Hermida JS
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1523-1533. PubMed ID: 29759834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.